Maite Bourlon, Associate Professor and Head of the Urologic Oncology Clinic at the National Institute of Medical Sciences and Nutrition Salvador Zubirán, shared on X:
“Mexican Society of Urological Oncology!
Prostate cancer case discussion Chemotherapy vs Lutetium vs PARP inhibitors.
Wonderful debate on Bladder preservation after PCR after neo-adyuvant EV+P.”
Read also “Prostate Cancer: New ESTRO Recommendations for Precision Radiotherapy” on OncoDaily.
